While enclomiphene protocols are available in all U.S
Tirzepatide (branded as Mounjaro) is FDA-approved and targets GLP-1 and GIP receptors
Programs that lean on compounding do so within that regulatory frame, and the specifics of preparation, concentration, and labeling belong to the dispensing pharmacy rather than to the telehealth brand
Trimi publishes $99/$125 on annual plans with a stated all-inclusive structure
These drugs are not magic and carry risks - GI issues, gallbladder problems, lean mass loss if protein intake is inadequate, and long-term unknowns require thoughtful prescribing, monitoring, and integration with strength training, proper nutrition, and sleep rather than replacement of these fundamentals
PubMed, Wessel, Jennifer, et al